Adrenal suppression with topical hydrocortisone butyrate.
D015062:11-Hydroxycorticosteroids / Q000097:blood; D015068:17-Ketosteroids / Q000652:urine; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000008:administration & dosage / Q000627:therapeutic use; D002250:Carbon Radioisotopes; D005260:Female; D005453:Fluorescence; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011565:Psoriasis / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use
D015062:11-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000893:Anti-Inflammatory Agents; D002087:Butyrates; D002250:Carbon Radioisotopes; D009824:Ointments; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone